ob体育 has commenced civil penalty proceedings in the Federal Court against Holista CollTech Limited (ASX:HCT) (Holista) and its Executive Chairman and CEO, Dr Rajendran Marnickavasagar, for alleged misleading statements regarding the sale orders for its sanitiser product and its effectiveness against the coronavirus involved in the Wuhan outbreak, later named COVID-19.
Dr Marnickavasagar claimed in a YouTube video in February 2020 that Holista鈥檚 鈥楴atShield鈥� sanitiser spray killed the coronavirus 鈥榠nvolved in the current Wuhan outbreak鈥�. ob体育 alleges that this was misleading as the product had not been tested against COVID-19.聽 Testing of the product against a feline coronavirus surrogate of COVID-19 commenced at a later date.
ob体育 also alleges that on 9 April 2020, Holista announced to the Australian Securities Exchange (ASX) that Health Therapies LLC (Health Therapies) had placed orders for 415,000 bottles of NatShield, totalling $3.8 million, for delivery between April and June 2020, when those orders had not been placed.
Subsequently, on 9 July 2020, Holista updated the market that the forecasted sales by 30 June 2020 worth $3.8 million from Health Therapies would not be met, as Holista鈥檚 expected revenue for the sale of NatShield to all customers for the year to 30 June 2020 was now $500,000.
ob体育 also alleges that Holista made a misleading statement that it had, in February 2020, executed a Binding Term Sheet with another company to co-develop a new sanitising nasal balm. ob体育 alleges that the agreement was actually executed in April 2020, rather than in February as stated.
鈥榦b体育 continues to focus on suspected misleading statements made to the market聽during the pandemic. In this case, we are concerned by the allegedly misleading claims, made when there were concerns about a potential pandemic, that NatShield was effective against the virus later known as COVID-19 when it had not been tested against that virus,鈥� said ob体育 Deputy Chair Sarah Court.
ob体育 alleges contraventions by Holista of sections 1041H and 674 of the Corporations Act and by Dr Marnickavasagar of sections 180 and 1309 of the Corporations Act.
ob体育 is seeking declarations and pecuniary penalties from the Federal Court against Holista and Dr Marnickavasagar and an order to ban Dr Marnickavasagar from managing a corporation.
Download
Background
Holista is a Western Australian based company, principally focused on the development of natural health foods and associated products. Holista distributes an alcohol-free, natural sanitiser spray product called 鈥楴atShield鈥�. On 22 April 2020, Holista had a market capitalisation of approximately $49.5 million. On 4 August 2021, Holista鈥檚 market capitalisation was approximately $18.17 million. The company has offices in Malaysia and Perth.
In October 2020, ob体育 issued administrative Determinations under ss713(6) and 708A of the Corporations Act making Holista ineligible to issue a reduced-content prospectus, and to use exemptions for reduced disclosure in any sale offer of its securities until 17 October 2021. These Determinations require Holista to issue full disclosure documents when raising funds until 17 October 2021(20-250MR).
Editor's note 1:聽
ob体育 and the defendants attended a mediation on 28 April 2022. The mediation was adjourned and the matter is listed for a case management hearing on 8 June 2022.聽
Editor's note 2:
The case management hearing on 8 June 2022 was vacated. A further case management hearing has been listed on 19 October 2022.
Editor's note 3:
The case management hearing has been adjourned to 16 November 2022.
Editor's note 4:
The case management hearing of 16 November 2022 was vacated. A case management hearing has been listed on 1 February 2023.
Editor's note 5:
The case management hearing of 1 February 2023 was vacated. A case management hearing has been listed on 1 March 2023.
Editor's note 6:
The proceedings against Holista CollTech Limited and Dr Rajendran Marnickavasagar has been listed for liability hearing before Justice Jackson of the Federal Court of Australia from 8 October to 20 October 2023 and then 4 December to 8 December 2023.
Editor's note 7:
The liability hearing before Justice Jackson of the Federal Court scheduled from 9 October to 20 October 2023 has been vacated.
The matter is listed for hearing on 6 and 7 December 2023 on the questions of: (1) the liability of both defendants, which is the subject of an agreed statement of facts and admissions and joint submissions, (2) the relief and penalty against the first defendant; and (3) the relief and penalty against the second defendant, which is subject to the joint submissions.